University of California at Davis UC Davis Hemostasis and Thrombosis Center
Welcome,         Profile    Billing    Logout  
 2 Trials 
10 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Giermasz, Adam
ATHN 16, NCT04647227: SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors

Recruiting
4
55
US
coagulation factor VIIa [recombinant]-jncw, SEVENFACT
American Thrombosis and Hemostasis Network, LFB USA, Inc.
Hemophilia A With Inhibitor, Hemophilia B With Inhibitor
09/26
03/27
NCT03003533: A Gene Transfer Study for Hemophilia A

Completed
1/2
25
Canada, US, RoW
SPK-8011
Spark Therapeutics, Inc.
Hemophilia A
12/23
12/23
Crary, Shelley
ATHN 16, NCT04647227: SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors

Recruiting
4
55
US
coagulation factor VIIa [recombinant]-jncw, SEVENFACT
American Thrombosis and Hemostasis Network, LFB USA, Inc.
Hemophilia A With Inhibitor, Hemophilia B With Inhibitor
09/26
03/27
PINES, NCT03939637: Eltrombopag Vs Standard Front Line Management for Newly Diagnosed Immune Thrombocytopenia (ITP) in Children

Active, not recruiting
3
122
US
Eltrombopag, Steroids, IVIG, Rho(D) Immune Globulin
Baylor College of Medicine, Boston Children's Hospital, University of California, San Francisco
Immune Thrombocytopenia
03/25
12/25
NCT04583878: FUVID Study: Functional Characterization of Children With Chronic Venous Thromboembolic Disease

Recruiting
N/A
125
US
Blood draw (Visit 1), Blood draw (Visits 2 and 3)
University of Texas Southwestern Medical Center
Deep Venous Thrombosis, Pulmonary Embolism
06/25
12/25
ATHN Transcends, NCT04398628: A Natural History Study of Non-Neoplastic Hematologic Disorders

Recruiting
N/A
3000
US
American Thrombosis and Hemostasis Network, Pfizer, Hemophilia of Georgia, Inc., Genentech, Inc., Hemab Therapeutics, CSL Behring, Sanofi, Novo Nordisk A/S
Hematologic Disorder, Bleeding Disorder, Connective Tissue Disorder, Hemophilia, Thrombosis, Von Willebrand Diseases, Thrombophilia, Rare Bleeding Disorder, Platelet Disorder, Factor IX Deficiency, Factor VIII Deficiency, Thalassemia, Sickle Cell Disease
06/35
12/35
Pierce, Carol D'Ann
ATHN 16, NCT04647227: SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors

Recruiting
4
55
US
coagulation factor VIIa [recombinant]-jncw, SEVENFACT
American Thrombosis and Hemostasis Network, LFB USA, Inc.
Hemophilia A With Inhibitor, Hemophilia B With Inhibitor
09/26
03/27
THRIVE-132, NCT04927247: A Study of a Single Dose of Inclacumab to Reduce Re-admission in Participants With Sickle Cell Disease and Recurrent Vaso-occlusive Crises

Terminated
3
72
Europe, US, RoW
Inclacumab, Placebo
Pfizer
Sickle Cell Disease, Vaso-occlusive Crisis, Vaso-occlusive Pain Episode in Sickle Cell Disease
11/23
11/23
THRIVE-131, NCT04935879: A Study to Assess the Safety and Efficacy of Inclacumab in Participants With Sickle Cell Disease Experiencing Vaso-occlusive Crises

Completed
3
243
Europe, US, RoW
Inclacumab, Placebo
Pfizer
Sickle Cell Disease, Vaso-occlusive Pain Episode in Sickle Cell Disease, Vaso-occlusive Crisis
06/24
06/24
NCT04583878: FUVID Study: Functional Characterization of Children With Chronic Venous Thromboembolic Disease

Recruiting
N/A
125
US
Blood draw (Visit 1), Blood draw (Visits 2 and 3)
University of Texas Southwestern Medical Center
Deep Venous Thrombosis, Pulmonary Embolism
06/25
12/25

Download Options